pantoprazole and Kidney Failure, Chronic studies

pantoprazole and Kidney Failure, Chronic

Pantoprazole: 2-pyridinylmethylsulfinylbenzimidazole proton pump inhibitor that is used in the treatment of GASTROESOPHAGEAL REFLUX and PEPTIC ULCER.
pantoprazole : A member of the class of benzimidazoles that is 1H-benzimidazole substituted by a difluoromethoxy group at position 5 and a [(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl group at position 2.

Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.

Research Excerpts

Excerpt	Relevance	Reference
"Pantoprazole is a selective inhibitor of the gastric H+/K+-ATPase with a low potential to interact with the cytochrome P450 enzyme system."	1.30	Pharmacokinetics of pantoprazole in patients with end-stage renal failure. ( Bahlmann, J; Hartmann, M; Huber, R; Kliem, V; Lühmann, R; Wurst, W, 1998)

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

1 (50.00)

18.2507

2000's

0 (0.00)

29.6817

2010's

1 (50.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Cervelli, MJ	1
Shaman, A	1
Meade, A	1
Carroll, R	1
McDonald, SP	1
Kliem, V	1
Bahlmann, J	1
Hartmann, M	1
Huber, R	1
Lühmann, R	1
Wurst, W	1

Studies

Cervelli, MJ

Shaman, A

Meade, A

Carroll, R

McDonald, SP

Kliem, V

Bahlmann, J

Hartmann, M

Huber, R

Lühmann, R

Wurst, W

Trials

1 trial available for pantoprazole and Kidney Failure, Chronic

Article	Year
Effect of gastric acid suppression with pantoprazole on the efficacy of calcium carbonate as a phosphate binder in haemodialysis patients. Nephrology (Carlton, Vic.), 2012, Volume: 17, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Biomarkers; Calcium; Calcium Carbo	2012

Article

Year

Effect of gastric acid suppression with pantoprazole on the efficacy of calcium carbonate as a phosphate binder in haemodialysis patients.

Nephrology (Carlton, Vic.), 2012, Volume: 17, Issue:5

Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Aged, 80 and over; Biomarkers; Calcium; Calcium Carbo

2012

Other Studies

1 other study available for pantoprazole and Kidney Failure, Chronic

Article	Year
Pharmacokinetics of pantoprazole in patients with end-stage renal failure. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1998, Volume: 13, Issue:5 Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Blood Proteins; Dialysis Solutions; Enzyme	1998

Article

Year

Pharmacokinetics of pantoprazole in patients with end-stage renal failure.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1998, Volume: 13, Issue:5

Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Benzimidazoles; Blood Proteins; Dialysis Solutions; Enzyme

1998